|19th August 2020||R Matthew Neff||5,000||Open or private purchase||$4.75||$23,750.00|
|19th August 2020||John E Sagartz||3,733||Open or private purchase||$4.75||$17,731.75|
|15th June 2020||Robert Jr. Leasure||2,884||Open or private purchase||$5.20||$14,996.80|
|10th June 2020||Beth Taylor||10,000||Grant/award etc.||$0.00|
|21st May 2020||Beth Taylor||3,300||Open or private purchase||$4.52||$14,916.00|
|21st May 2020||William D Pitchford||10,000||Open or private purchase||$4.47||$44,700.00|
|20th May 2020||Beth Taylor||4,933||Open or private purchase||$4.42||$21,803.86|
|19th May 2020||Beth Taylor||5,067||Open or private purchase||$4.38||$22,193.46|
|1st April 2020||Richard Allen Johnson||10,000||Grant/award etc.||$0.00|
|1st April 2020||R Matthew Neff||10,000||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Bioanalytical Systems, Inc. operates as a pharmaceutical development company. It engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products.